Principal Financial Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $13M | Sell |
|
|||||
|
2024
Q4 | $19.6M | Sell |
|
|||||
|
2024
Q3 | $27.1M | Buy |
|
|||||
|
2024
Q2 | $14.8M | Sell |
|
|||||
|
2024
Q1 | $18.8M | Buy |
|
|||||
|
2023
Q4 | $18.5M | Buy |
|
|||||
|
2023
Q3 | $12.6M | Buy |
|
|||||
|
2023
Q2 | $443K | Sell |
|
|||||
|
2023
Q1 | $373K | Buy |
|
|||||
|
2022
Q4 | $404K | Buy |
|
|||||
|
2022
Q3 | $99K | Buy |
|
|||||
|
2022
Q2 | $60K | Buy |
|
|||||
|
2022
Q1 | $72K | Sell |
|
|||||
|
2021
Q4 | $117K | Sell |
|
|||||
|
2021
Q3 | $169K | Sell |
|
|||||
|
2021
Q2 | $239K | Buy |
|
|||||
|
2021
Q1 | $313K | Sell |
|
|||||
|
2020
Q4 | $1.28M | Buy |
|